Table 5 Assessment of bacteremia and positive procalcitonin as a risk for gastrointestinal bleeding among studied population (n = 99)
Blood culture | Group (I) Patient with first attack of bleeding (n = 35) | Group (II) Patient with recurrent bleeding (n = 35) | Group (III) Control patients (n = 29) | |||
No. | % | No. | % | No. | % | |
Positive | 16 | 45.7% | 21 | 60% | 7 | 24.1% |
Negative | 19 | 54.3% | 14 | 40% | 22 | 75.9% |
Odds ratio (OR) | 2.65 | |||||
4.71 | ||||||
Procalcitonin | Group (I) Patient with first attack of bleeding (n = 35) | Group (II) Patient with Recurrent bleeding (n = 35) | Group (III) Control patients (n = 29) | |||
No. | % | No. | % | No. | % | |
Positive | 15 | 42.9% | 21 | 60% | 6 | 20.7% |
Negative | 20 | 57.1% | 14 | 40% | 23 | 79.3% |
Odds ratio (OR) | 2.87 | |||||
5.75 | ||||||